NCT Number: NCT01907152
Increase Protein Intake in Elderly
The objective of this study is to investigate the acceptance, intake, and compliance of protein enriched bread and protein enriched yoghurt drinks in elderly patients in two real life settings (short term; hospital, and longer term; rehabilitation home).
Looking for future studies?
Notify MeKey information
Conditions
Age range
55 year and older
Sex eligibility
All sexes
Study type
Interventional
Phase
Not applicable
Primary location
VU university medical center, Amsterdam, Netherlands
About this study
Prevalence rates of protein-energy malnutrition in elderly are high. In order to prevent loss of muscle mass and remain physically independent, it is utmost important for elderly to maintain their body protein mass. A sufficient protein supply according to their needs is therefore highly important. Especially for frail elderly, it is not easy to realize an increased protein intake by simply eating more. It is hypothesized that protein enriched food products that fit in a habitual diet (dairy and bread), result in a higher protein intake compared to regular products.
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- admitted to the department of internal medicine of VU university medical center or to the rehabilitation department of "Herstelhotel Dekkerswald"
- signed informed consent
- age of 55 or more
- rehabilitating from a hospital stay with the aim to return back home (rehabilitation home only)
- likely to remain admitted at least 3 weeks (rehabilitation home only).
Exclusion criteria
- not speaking Dutch language
- allergy for milk, soy or gluten
- a medical condition that is considered by the treating physician as a contra indication for receiving protein enriched food products
- a diet that does not allow the use of normal bread or dairy products (e.g. fluid diet, strong sodium restricted diet)
- not able to eat or feed themselves
- receiving tube feeding or parenteral nutrition
- suffering from a terminal illness
Treatment and study plan
Primary outcomes
-
Protein intake measured on an individual level over 24h
Time frame: 3 days (hospital), 3 weeks (rehabilitation home)
Secondary outcomes
-
Intake of macronutrients (besides protein), total energy, calcium and fibre measured on an individual level over 24h.
Time frame: 3 days (hospital), 3 weeks (rehabilitation home)
Other outcomes
-
Product evaluation
Time frame: 3 days (hospital), 3 weeks (rehabilitation home)
Questionnaire on appreciation and acceptance of protein enriched food products
Sponsors and collaborators
Lead sponsor
Wageningen University and Research
Other
Collaborators
- Amsterdam UMC, location VUmc
- Carezzo B.V.
- Fonterra (Europe) Cooperatie U.A.
- Hogeschool van Arnhem en Nijmegen (HAN)
Registry information
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2014
- First posted
- Jul 24, 2013
- Registry last updated
- May 16, 2014
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
The Reduced Calorie Food and Mood Study
NCT04138862
Markedly Reduced Food Intake, Satiety and Food Intake
Singapore
View Trial DetailsSuitability of Two Flavours of a High-energy, Low-protein Formula (Renalive® LP) in Chronic Kidney Disease Stage 3b-5 Outpatients in Taiwan
NCT06892249
CKD, Low Protein Dietary Intake
Kaohsiung City, Taiwan
View Trial DetailsDysphagia Management for Caregivers of Stroke Patients
NCT07181629
Behavior, Behavioral Symptoms
Kütahya, Turkey (Türkiye)
View Trial DetailsIntegrated Bedside Assessment and Prognosis in Hospitalized Patients With Metastatic Cancer
NCT07167082
Atrophy, Body Weight
Ankara, Yenimahalle, Turkey (Türkiye)
View Trial Details